Table_1_Reduced Growth of Staphylococcus aureus Under High Glucose Conditions Is Associated With Decreased Pentaglycine Expression.DOC حسب Zhen Luo (281825)

"…Cells of S. aureus from the culture medium with glucose had a thinner cell wall and highly resistant to lysostaphin compared with the bacteria cultured in LB medium. mRNA expression of genes encoding pentaglycine bridges, the substrate of lysostaphin, was significantly decreased in S. aureus by glucose. …"

Supplementary Figures S1-S9 from Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death حسب Eric A. Lee (14918913)

Figure S6 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies حسب Rodrigo A. Toledo (14996709)

DataSheet1_Research on prescribing cascades: a scoping review.docx حسب Zhe Chen (196097)

Figure 4 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i>-Altered Tumors حسب Constance A. Sobsey (19373550)

Figure 2 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i>-Altered Tumors حسب Constance A. Sobsey (19373550)

Figure S1 from The <i>MCT4</i> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer حسب Stephen Yiu Chuen Choi (14996076)

Figure 5 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma حسب Marianna Carrabotta (8193039)

Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy حسب Michael F. Emmons (14935638)

Figure 1 from Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study حسب Clinton Yam (18716936)

(A) The distribution of mutations within the 3D structure of the TP53 protein. حسب Ashraf Attia Mahmoud (21262201)

الموضوعات:

(A) Pie chart showing the distribution of mutation types identified within the TP53 gene. حسب Ashraf Attia Mahmoud (21262201)

الموضوعات:

Data Supplement from Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma حسب Anaïs Balbous (3425822)

Supplementary Figures from Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell... حسب Chia-Wen Liu (708076)

Figure 3 from Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial حسب Santeri A. Pakola (19530073)

Noise decrease rate comparison. حسب Xianlin Ren (22783589)

Figure 6 from PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells حسب Zachary A. Schaaf (12912100)

Figure 5 from PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells حسب Zachary A. Schaaf (12912100)

Data Sheet 1_Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.docx حسب Alina Tscherne (8544519)

"…However, many important advancements have been made in terms of PUUV research over the last years. This included the elucidation of its glycoproteins, the discovery of broadly neutralizing hantavirus antibodies as therapeutic candidates and expanded research on the mRNA vaccine technology which will likely enable the development of strong PUUV vaccine candidates in the near future. …"

Figure S2 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer حسب Erika S. Dahl (15078264)